FDA Finalizes Guidance Closing Pediatric Study Loophole

The US Food and Drug Administration (FDA) on Thursday finalized guidance stating that it does not intend to grant orphan drug designation for pediatric subpopulations of common diseases in an effort to close a loophole in the Pediatric Research Equity Act (PREA).